Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
New England Journal of Medicine · 11.05.2023 · 388 (19) · 1755-1766
DOI: 10.1056/nejmoa2212895 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 11.05.2023. Verfasst von Matthew Greenhawt und 59 weiteren Autor:innen. Beteiligte Einrichtung: From the Section of Allergy and Immunology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora…. Hauptthemen laut MEDLINE: Anaphylaxis, Desensitization, Immunologic, Peanut Hypersensitivity. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: DBV Technologies.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Section of Allergy and Immunology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (M.G., D.M.F.); the Sean N. Parker Center for Allergy and Asthma Rese…
ORCID-Profile: Peter D Arkwright, Morna J Dorsey, Christopher Parrish, Julia E Upton
Förderung
- DBV Technologies
Zitieren
APA
Greenhawt, M., Sindher, S. B., Wang, J., O'Sullivan, M., du Toit, G., Kim, E. H., Albright, D., Anvari, S., Arends, N., Arkwright, P. D., Bégin, P., Blumchen, K., Bourrier, T., Brown-Whitehorn, T., Cassell, H., Chan, E. S., Ciaccio, C. E., Deschildre, A., Divaret-Chauveau, A., …, & Green, T. D. (2023). Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. New England Journal of Medicine, 388(19), 1755-1766. https://doi.org/10.1056/nejmoa2212895
Vancouver
Greenhawt M, Sindher SB, Wang J, O'Sullivan M, du Toit G, Kim EH, et al. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. New England Journal of Medicine. 2023;388(19):1755-1766. doi:10.1056/nejmoa2212895
BibTeX
@article{Greenhawt2023,
author = {Greenhawt, Matthew and Sindher, Sayantani B and Wang, Julie and O'Sullivan, Michael and du Toit, George and Kim, Edwin H and Albright, Deborah and Anvari, Sara and Arends, Nicolette and Arkwright, Peter D and Bégin, Philippe and Blumchen, Katharina and Bourrier, Thierry and Brown-Whitehorn, Terri and Cassell, Heather and Chan, Edmond S and Ciaccio, Christina E and Deschildre, Antoine and Divaret-Chauveau, Amandine and Dorris, Stacy L and Dorsey, Morna J and Eiwegger, Thomas and Erlewyn-Lajeunesse, Michel and Fleischer, David M and Ford, Lara S and Garcia-Lloret, Maria and Giovannini-Chami, Lisa and Hourihane, Jonathan O and Jay, Nicola and Jones, Stacie M and Kerns, Leigh Ann and Kloepfer, Kirsten M and Leonard, Stephanie and Lezmi, Guillaume and Lieberman, Jay A and Lomas, Jeanne and Makhija, Melanie and Parrish, Christopher and Peake, Jane and Perrett, Kirsten P and Petroni, Daniel and Pfützner, Wolfgang and Pongracic, Jacqueline A and Quinn, Patrick and Robison, Rachel G and Sanders, Georgiana and Schneider, Lynda and Sharma, Hemant P and Trujillo, Juan and Turner, Paul J and Tuttle, Katherine and Upton, Julia E and Varshney, Pooja and Vickery, Brian P and Vogelberg, Christian and Wainstein, Brynn and Wood, Robert A and Bee, Katharine J and Campbell, Dianne E and Green, Todd D},
title = {Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {19},
pages = {1755--1766},
doi = {10.1056/nejmoa2212895}
}
EUVIMED